Alerts will be sent to your verified email
Verify EmailBROOKS
|
Brooks Laboratories
|
Kimia Biosciences
|
Coral Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 24.83 % | 8.16 % |
|
5yr average Equity Multiplier
|
1.68 | 66.02 | 1.18 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 1.14 | 0.47 |
|
5yr Avg Net Profit Margin
|
-21.45 % | -0.67 % | 14.82 % |
|
Price to Book
|
1.19 | 11.74 | 0.65 |
|
P/E
|
6.39 | 14.11 | 9.89 |
|
5yr Avg Cash Conversion Cycle
|
23.75 Days | -33.97 Days | 35.5 Days |
|
Inventory Days
|
83.11 Days | 101.63 Days | 69.25 Days |
|
Days Receivable
|
80.26 Days | 98.68 Days | 98.13 Days |
|
Days Payable
|
163.46 Days | 171.28 Days | 131.4 Days |
|
5yr Average Interest Coverage Ratio
|
-11.18 | 0.78 | 171.88 |
|
5yr Avg ROCE
|
-11.18 % | 10.6 % | 10.48 % |
|
5yr Avg Operating Profit Margin
|
-10.26 % | 3.89 % | 14.88 % |
|
5 yr average Debt to Equity
|
0.18 | 29.85 | 0.02 |
|
5yr CAGR Net Profit
|
-12.45 % | 13.51 % | 12.26 % |
|
5yr Average Return on Assets
|
-13.31 % | -0.69 % | 6.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 74.94 % | 71.51 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | 0.0 | 0.0 |
|
Brooks Laboratories
|
Kimia Biosciences
|
Coral Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|